Author

Wenshu Lu

Institution: University of Oxford

Observed institution: University of Oxford

OpenAlex ID: A5159734591

OVM-200, a recombinant overlapping peptide vaccine, breaks immune tolerance to survivin in patients with advanced solid tumours: a multicentre, open-label, dose-expansion, phase 1 study

2026 · Peter Kok-Ting Wan, Thomas Morris, et al. · medRxiv

Therapeutic HPV16 E7 vaccination with CD137 agonism induces tumor regression and durable immunity in mice

2026 · Yuqian Ou, Wenshu Lu, et al. · iScience

Works count: 2

Citation count:

H-index:

I10-index: